Ixj: Pure Pharma Against—A Global Healthcare Bet Today
Two popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...
We break down no-load fund options for IRAs and what that means for your purchasing costs. Find transparent choices that keep more of your money invested.
27,130 articlesTwo popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...
Kalshi launches LINKPERP, a CFTC-regulated Chainlink perpetual contract, coinciding with LINK ETF assets surpassing $...
Energy markets swing, yet Enterprise Products Partners has built a resilient income stream through a toll-road model....
The National Association of Realtors reports a small February uptick in nar: pending home sales, but the index remain...
Two major travel stocks have caught the eye of billionaire activist investors. This article breaks down what could ha...
A growing platform rolls out an AI tool that lets users convert ideas into investable indices, with an uncapped 1% ma...
The MBA reports a sharp drop in loan applications as the 30-year fixed rate climbs to 6.3%, the highest in months. Re...
Mortgage applications fell as the 30-year fixed rate climbed to 6.65%, the highest since August 2025. Refinance deman...
Two private-credit funds unveiled exit options for locked-up investors, offering steep discounts and renewed liquidit...
CrowdStrike recently completed a stock split, sparking questions about its impact on liquidity and valuation. This gu...
As Uniti maps out its path for 2026, investors want clarity on revenue, cash flow, and growth prospects. This guide b...
A famous public clash from 2013 reshaped how we think about money, risk, and accountability. This finance-forward loo...